Design of potent linear alpha-melanotropin 4-10 analogues modified in positions 5 and 10
about
Fluorescence study of conformational properties of melanotropins labeled with aminobenzoic acid.Conformational study on cyclic melanocortin ligands and new insight into their binding mode at the MC4 receptor.Interactions of the melanocortin-4 receptor with the peptide agonist NDP-MSH.Systematic Backbone Conformational Constraints on a Cyclic Melanotropin Ligand Leads to Highly Selective Ligands for Multiple Melanocortin Receptors.Temporal cAMP Signaling Selectivity by Natural and Synthetic MC4R Agonists.The melanocortin circuit in obese and lean strains of chicksEmerging approaches in the molecular design of receptor-selective peptide ligands: conformational, topographical and dynamic considerations.Melanotropic peptides for therapeutic and cosmetic tanning of the skin.Design, synthesis, and conformation of superpotent and prolonged acting melanotropins.The first preparative solution phase synthesis of melanotan II.Beta-turn secondary structure and melanocortin ligands.Linear and cyclic alpha-melanotropin [4-10]-fragment analogues that exhibit superpotency and residual activity.Conformation of the core sequence in melanocortin peptides directs selectivity for the melanocortin MC3 and MC4 receptors.Replacement of Arg with Nle and modified D-Phe in the core sequence of MSHs, Ac-His-D-Phe-Arg-Trp-NH2, leads to hMC1R selectivity and pigmentation.
P2860
Q28344556-EBA1A6AB-0287-4A27-85BA-C2B3F4F93E8EQ33926210-CDDB6AE1-6E1E-476B-9BF5-3E7EE9BA3D9DQ35004622-5424A96B-DAD5-46A9-9256-71C7DD46A62EQ36128120-6656EE7B-55A8-4D86-8386-9E23D1B9250FQ36232983-A0B56C8B-2995-42DA-97A9-27E37A151CC4Q37313789-030117DD-2A7B-4512-99DC-A5C0224F65A5Q37884199-73E706B0-008B-4A25-A114-73BFA5B16711Q40855171-F843CCFB-8AFE-4C77-8CA8-899DB09B2D97Q40855176-C8E9B0FF-B007-47F7-A202-83BFCF2F3490Q41621186-DDB2BDC1-A57D-40BA-8505-2A99BF19BCA3Q41957100-2585C8D7-EAF7-4D3E-8803-E5A7C17E421AQ45066512-AF4742F9-3F72-4E3C-8CAD-E8800FFD2E82Q48192978-C6C2B932-6275-4DB0-95DC-2BE8C974FC1FQ55130069-3E2E5705-53BC-4DC2-9028-F485F58C4598
P2860
Design of potent linear alpha-melanotropin 4-10 analogues modified in positions 5 and 10
description
1989 nî lūn-bûn
@nan
1989 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Design of potent linear alpha-melanotropin 4-10 analogues modified in positions 5 and 10
@ast
Design of potent linear alpha-melanotropin 4-10 analogues modified in positions 5 and 10
@en
Design of potent linear alpha-melanotropin 4-10 analogues modified in positions 5 and 10
@nl
type
label
Design of potent linear alpha-melanotropin 4-10 analogues modified in positions 5 and 10
@ast
Design of potent linear alpha-melanotropin 4-10 analogues modified in positions 5 and 10
@en
Design of potent linear alpha-melanotropin 4-10 analogues modified in positions 5 and 10
@nl
prefLabel
Design of potent linear alpha-melanotropin 4-10 analogues modified in positions 5 and 10
@ast
Design of potent linear alpha-melanotropin 4-10 analogues modified in positions 5 and 10
@en
Design of potent linear alpha-melanotropin 4-10 analogues modified in positions 5 and 10
@nl
P2093
P356
P1476
Design of potent linear alpha-melanotropin 4-10 analogues modified in positions 5 and 10
@en
P2093
F Al-Obeidi
M E Hadley
P304
P356
10.1021/JM00121A032
P407
P577
1989-01-01T00:00:00Z